The effect of diet based on Persian Medicine on endometriosis

The effect of Diet based on Persian Medicine on Pain and Extent of Lesions in Patients with Endometriosis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230613058473N1

Enrollment

Registered

2023-08-28

Start date

2023-10-22

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriosis. Endometriosis

Interventions

Intervention 1: Intervention group: In this group, a diet based on Iranian medicine is given to patients for breakfast, lunch, and dinner, as well as morning and evening snacks and before bed. This di

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Iranian race Being at the age of 20 to 40 years Women with endometriosis who haven't been given medication yet Having pain symptoms

Exclusion criteria

Exclusion criteria: Smoking Alcohol consumption Diabetes

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: pain assessment before the study, in the first, second, third month (after the study). Method of measurement: Vas questionnaire.;Extent of endometriosis lesions. Timepoint: Evaluation of lesions before and after the study (3 months). Method of measurement: Endometriosis mapping sonography.	—

Secondary

Measure	Time frame
Chronic pelvic pain. Timepoint: Before the study, visit in the first month, second month and third month (after the study). Method of measurement: visual analog scale (VAS).;Dysmenorrhea. Timepoint: Before the study, visit in the first month, second month and third month (after the study ). Method of measurement: visual analog scale (VAS).;Dyschezia. Timepoint: Before the study, visit in the first month, second month and third month (after the study ). Method of measurement: visual analog scale (VAS).;Dysuria. Timepoint: Before the study, visit in the first month, second month and third month (after the study ). Method of measurement: visual analog scale (VAS).;Dyspareunia. Timepoint: Before the study, visit in the first month, second month and third month (after the study ). Method of measurement: visual analog scale (VAS).;Quality of life. Timepoint: Before the study, visit in the first month, second month and third month (after the study ). Method of measurement: EHP_30 questionnaire.;Taking painkillers. Timepoint: Before the study, visit in the first month, second month and third month (after the study ). Method of measurement: Asking the patient.	—

Measure

Time frame

Chronic pelvic pain. Timepoint: Before the study, visit in the first month, second month and third month (after the study). Method of measurement: visual analog scale (VAS).;Dysmenorrhea. Timepoint: Before the study, visit in the first month, second month and third month (after the study ). Method of measurement: visual analog scale (VAS).;Dyschezia. Timepoint: Before the study, visit in the first month, second month and third month (after the study ). Method of measurement: visual analog scale (VAS).;Dysuria. Timepoint: Before the study, visit in the first month, second month and third month (after the study ). Method of measurement: visual analog scale (VAS).;Dyspareunia. Timepoint: Before the study, visit in the first month, second month and third month (after the study ). Method of measurement: visual analog scale (VAS).;Quality of life. Timepoint: Before the study, visit in the first month, second month and third month (after the study ). Method of measurement: EHP_30 questionnaire.;Taking painkillers. Timepoint: Before the study, visit in the first month, second month and third month (after the study ). Method of measurement: Asking the patient.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamideh Vaezi Jazani

Shahid Beheshti University of Medical Sciences

v.hamideh@gmail.com+98 21 8877 3521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026